chronic idiopathic urticaria
Showing 1 - 22 of 22
Chronic Idiopathic Urticaria Trial (Omalizumab Injection, Xolair Prefilled Syringe)
Not yet recruiting
- Chronic Idiopathic Urticaria
- Omalizumab Injection
- Xolair Prefilled Syringe
- (no location specified)
Mar 7, 2023
Chronic Idiopathic Urticaria Trial (5-mg Desloratadine, 10-mg Desloratadine, 20-mg Desloratadine)
Completed
- Chronic Idiopathic Urticaria
- 5-mg Desloratadine
- +2 more
- (no location specified)
Feb 7, 2022
Chronic Idiopathic Urticaria, Atopy Trial (desloratadine, Placebo)
Completed
- Chronic Idiopathic Urticaria
- Atopy
- desloratadine
- Placebo
- (no location specified)
Feb 7, 2022
Chronic Idiopathic Urticaria, Chronic Idiopathic Pruritus, Lichen Planus Trial in United States (KPL-716, Placebo)
Completed
- Chronic Idiopathic Urticaria
- +4 more
- KPL-716
- Placebo
-
Anniston, Alabama
- +18 more
Nov 29, 2021
Mast Cell Activation Test in Allergic Disease
Completed
- Asthma
- +6 more
-
Hong Kong, Hong KongHong Kong Sanatorium & Hospital
Mar 27, 2020
Chronic Idiopathic Urticaria Trial in Cincinnati (benralizumab, )
Completed
- Chronic Idiopathic Urticaria
- benralizumab
- placebo
-
Cincinnati, OhioBernstein Clinical Research Center
Jul 8, 2019
Chronic Idiopathic Urticaria Trial in Seattle (Xolair)
Completed
- Chronic Idiopathic Urticaria
- Xolair
-
Seattle, WashingtonASTHMA Inc Clinical Research Center
Jan 22, 2019
Chronic Idiopathic Urticaria Trial in Baltimore (AZD1981, Placebo)
Completed
- Chronic Idiopathic Urticaria
- AZD1981
- Placebo
-
Baltimore, MarylandJohns Hopkins Asthma and Allergy Center
Jun 13, 2017
Chronic Idiopathic Urticaria Trial (omalizumab, , H1 antihistamines)
Chronic Idiopathic Urticaria Trial in Zurich (Canakinumab, Placebo)
Unknown status
- Chronic Idiopathic Urticaria
- Canakinumab
- Placebo
-
Zurich, SwitzerlandUniversity Hospital Zurich, Division of Dermatology
Sep 26, 2016
Chronic Idiopathic Urticaria Trial in Salt Lake City (etanercept, )
Withdrawn
- Chronic Idiopathic Urticaria
- etanercept
- placebo
-
Salt Lake City, UtahUniversity of Utah Department of Dermatology
May 29, 2015
Chronic Idiopathic Urticaria Trial in Germany (IGE025, )
Chronic Idiopathic Urticaria Trial in Petah Tikva (Omalizimab)
Unknown status
- Chronic Idiopathic Urticaria
-
Petah Tikva, IsraelRabin Medical Center
Jun 17, 2014
Chronic Urticaria, Chronic Idiopathic Urticaria, Chronic Spontaneous Urticaria Trial in Bern (Omalizumab (Xolair), Placebo)
Completed
- Chronic Urticaria
- +2 more
- Omalizumab (Xolair)
- Placebo
-
Bern, SwitzerlandDepartment of Rheumatology, Clinical Immunology and Allergology,
Apr 14, 2014
Chronic Idiopathic Urticaria Trial in Worldwide (Omalizumab, Placebo)
Chronic Idiopathic Urticaria Trial in Worldwide (Omalizumab, Placebo, H1 antihistamine, H2 antihistamine, leukotriene receptor
Chronic Idiopathic Urticaria Trial in Worldwide (Placebo, Omalizumab)
Chronic Idiopathic Urticaria Trial in Worldwide (Levocetirizine, Desloratadine)
Completed
- Chronic Idiopathic Urticaria
-
Brugge, Belgium
- +79 more
Aug 30, 2011
Chronic Idiopathic Urticaria, Urticaria Trial in Taipei (Denosin® and Xyzal®)
Unknown status
- Chronic Idiopathic Urticaria
- Urticaria
- Denosin® and Xyzal®
-
Taipei, TaiwanDepartment of Dermatology National Taiwan University Hospital
Jun 29, 2006